Clinical and complement data in patients with aHUS with anti-fH autoantibodies
Patient . | HUS onset . | First serum sample analyzed . | Current age and situation . | ||||||
---|---|---|---|---|---|---|---|---|---|
Age, y . | Plasma therapy . | Renal function . | Time after onset . | AutoAb titer, AU/mL* . | C3, mg/dL* . | C4, mg/dL* . | CFH, mg/dL* . | ||
H87 | 5 | PE | Full recovery | Onset | 600 | 55.7† | 8.85† | 25 | 11 y; unknown |
H108 | 4 | PE | Full recovery | 3 mo | 1600 | 86.2 | 28.4 | 22 | 8 y; ESRD |
H119 | 4 | None | ESRD | 13 y | 600 | 117 | 16.6 | 28 | 20 y; RT since 1995 |
H151 | 6 | PE + PI | Full recovery | 7 mo | 6000 | 66.7† | 16.7 | 31 | 8 y; stable with corticoids |
H154 | 8 | PE | Full recovery | Onset | 18 000 | 58.5† | 19.6 | 26 | 10 y; stable with azathioprine |
H171 | 3 | None | ESRD | 5 mo | 3600 | 81.3 | 40.6 | 25 | 4 y; RT since March 2009 |
H177 | 7 | PF + 5% albumin | Death (myocarditis) | Onset | 16 000 | 58.5† | 19.6 | 22 | Died during first episode |
Patient . | HUS onset . | First serum sample analyzed . | Current age and situation . | ||||||
---|---|---|---|---|---|---|---|---|---|
Age, y . | Plasma therapy . | Renal function . | Time after onset . | AutoAb titer, AU/mL* . | C3, mg/dL* . | C4, mg/dL* . | CFH, mg/dL* . | ||
H87 | 5 | PE | Full recovery | Onset | 600 | 55.7† | 8.85† | 25 | 11 y; unknown |
H108 | 4 | PE | Full recovery | 3 mo | 1600 | 86.2 | 28.4 | 22 | 8 y; ESRD |
H119 | 4 | None | ESRD | 13 y | 600 | 117 | 16.6 | 28 | 20 y; RT since 1995 |
H151 | 6 | PE + PI | Full recovery | 7 mo | 6000 | 66.7† | 16.7 | 31 | 8 y; stable with corticoids |
H154 | 8 | PE | Full recovery | Onset | 18 000 | 58.5† | 19.6 | 26 | 10 y; stable with azathioprine |
H171 | 3 | None | ESRD | 5 mo | 3600 | 81.3 | 40.6 | 25 | 4 y; RT since March 2009 |
H177 | 7 | PF + 5% albumin | Death (myocarditis) | Onset | 16 000 | 58.5† | 19.6 | 22 | Died during first episode |